In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

DuPont buys CombiChem for $95mm cash in tender offer

Executive Summary

To get itself a strong in-house unit to drive future product discovery efforts, DuPont Pharmaceuticals has agreed to buy computational drug discovery company CombiChem. Its tender offer of $95mm, or $6.75 per share, is a (pr)35% premium to the stock's 10-day average pre-announcement.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies